- ICH GCP
- US Clinical Trials Registry
- Search trials
Example: Heart Attack
Search clinical trials for: Bevacizumab
Total 2701 results
-
NCT06061809Not yet recruiting
-
NCT06060704RecruitingMetastatic Colorectal Cancer
-
NCT06057298RecruitingPeritoneal Metastases From Colorectal Cancer
-
NCT06047379Not yet recruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Small Cell Lung Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma
-
NCT06041490Not yet recruitingLiver Transplant; Complications | Recurrent Osteosarcoma | Hepatocarcinoma | High-Risk Cancer
-
NCT06040099Not yet recruiting
-
NCT06039202Not yet recruiting
-
NCT06037889Not yet recruitingBranch Atheromatous Disease
-
NCT06035133Not yet recruiting
-
NCT06031233Not yet recruitingOncology | Infusion Reaction
-
NCT06031285Recruiting
-
NCT06023862Not yet recruitingUterine Cervical Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Vulvar Cancer | Clear Cell Carcinoma | Vagina Neoplasm
-
NCT06011109Not yet recruitingGlioma | Glioblastoma Multiforme
-
NCT06011772Not yet recruiting
-
NCT06010667Not yet recruiting
-
NCT06008522Not yet recruitingBarrett Esophagus | Colon Carcinoma | Gastrointestinal Dysplasia
-
NCT06006286Not yet recruitingMetastatic Hepatocellular Carcinoma
-
NCT06008119Not yet recruitingColorectal Cancer Metastatic
-
NCT06003998RecruitingColorectal Cancer | Peritoneal Metastases
-
NCT06001281Not yet recruiting
-
NCT05998941Not yet recruiting
-
NCT05999812Not yet recruiting
-
NCT05992220RecruitingHepatocellular Carcinoma | Liver Cancer | Hepatocellular Carcinoma Non-resectable | Hepatocellular Cancer | Hepatocellular Carcinoma Stage IV
-
NCT05985798RecruitingHepatocellular Carcinoma Non-resectable
-
NCT05984511Not yet recruitingHepatocellular Carcinoma | Hepatic Portal Vein Tumor Invasion | Tumor Thrombus
-
NCT05983367RecruitingColorectal Cancer | Metastatic Colon Cancer
-
NCT05976568Not yet recruiting
-
NCT05975463Not yet recruiting
-
NCT05969899Recruiting
-
NCT05970302RecruitingBevacizumab | Capecitabine | Metastatic Colorectal Cancer (mCRC) | Oxaliplatin | Tislelizumab | First-Line | MSS/pMMR | RAS-mutated
-
NCT05970666Not yet recruitingHepatocellular Carcinoma | Bevacizumab | TACE | Adebrelimab | Transformation
-
NCT05965141Not yet recruiting
-
NCT05965154Not yet recruitingHead and Neck Squamous Cell Carcinoma
-
NCT05956821Not yet recruitingGlioblastoma Multiforme | Anaplastic Astrocytoma | Oligodendroglioma | Fibrillary Astrocytomas | Diffuse Intrinsic Brainstem Glioma
-
NCT05939310Not yet recruitingBreast Cancer | Breast Cancer Invasive
-
NCT05936606RecruitingCoronary Artery Disease
-
NCT05934799Recruiting
-
NCT05930665Not yet recruiting
-
NCT05926271RecruitingAcute Coronary Syndrome | CYP2C19 Polymorphism
-
NCT05929768RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast Carcinoma
-
NCT05908916Not yet recruitingHepatocellular Carcinoma
-
NCT05908786Recruiting
-
NCT05906524Not yet recruitingOther Solid Tumors | Advanced HCC
-
NCT05904886Recruiting
-
NCT05904457RecruitingAdvanced Solid Tumors | Metastatic Cancer | Solid Tumors
-
NCT05894694RecruitingAdvanced Colorectal Carcinoma
-
NCT05885932RecruitingIschemic Stroke | Vertebral Artery Stenosis
-
NCT05886465RecruitingHepatocellular Carcinoma